Laura van Dussen

Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response

Nick Dekker, Laura van Dussen, Carla E. M. Hollak et al. · Blood · 2011 · 290 citations

Life Sciences, Biochemistry, Molecular Medicine +12

Force Majeure: Therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease

Carla E. M. Hollak, Stephan vom Dahl, Johannes M. F. G. Aerts et al. · Blood Cells Molecules and Diseases · 2009 · 95 citations

Pharmacy, Biochemistry, Pharmacotherapy +3

Value of plasma chitotriosidase to assess non‐neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy

Laura van Dussen, Erik Hendriks, J.E.M. Groener et al. · Journal of Inherited Metabolic Disease · 2014 · 77 citations

Life Sciences, Molecular Medicine, Neurology +9

Short-Term Effect of Estrogen on Human Bone Marrow Fat

E.J. Limonard, Annegreet G. Veldhuis‐Vlug, Laura van Dussen et al. · Journal of Bone and Mineral Research · 2015 · 71 citations · Full text

Medicine, Endocrinology, Radiology +11

Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease

Laura van Dussen, Marieke Biegstraaten, Carla E. M. Hollak et al. · Orphanet Journal of Rare Diseases · 2014 · 71 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17